united therapeutics glp-1 receptor agonist Oral GLP-1-Based in the Obesity–Metabolic Syndrome–Diabetes Continuum: Translational Advances, Clinical Barriers, and Emerging Strategies GLP-1 Receptor Agonists as Treatments
Description
Gke R, Larsen PJ, Mikkelsen JD, Sheikh SP
Many patients describe feeling full sooner, needing smaller portions, or having quieter "food noise" persistent, intrusive thoughts about food reported by many patients with obesity
its about promoting long-term health and weight management
Masson, A
[DOI] [PubMed] [Google Scholar] 63.Vella A, Shah P, Reed AS, Adkins AS, Basu R, Rizza RA
